Search Results - "Glasberg, S S"

Refine Results
  1. 1

    Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors by Dworakowska, D, Wlodek, E, Leontiou, C A, Igreja, S, Cakir, M, Teng, M, Prodromou, N, Góth, M I, Grozinsky-Glasberg, S, Gueorguiev, M, Kola, B, Korbonits, M, Grossman, A B

    Published in Endocrine-related cancer (01-12-2009)
    “…Raf/MEK/ERK and phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) cascades are key signalling pathways interacting with each other…”
    Get full text
    Journal Article
  2. 2

    The role of hepatic trans-arterial chemoembolization in metastatic medullary thyroid carcinoma: a specialist center experience and review of the literature by Grozinsky-Glasberg, S, Bloom, A I, Lev-Cohain, N, Klimov, A, Besiso, H, Gross, D J

    Published in European journal of endocrinology (01-04-2017)
    “…Background Liver metastases are relatively common in patients with metastatic medullary thyroid carcinoma (MTC), carrying a negative impact on disease…”
    Get full text
    Journal Article
  3. 3

    Hepatic intra-arterial therapies in metastatic neuroendocrine tumors: lessons from clinical practice by Grozinsky-Glasberg, S., Kaltsas, G., Kaltsatou, M., Lev-Cohain, N., Klimov, A., Vergadis, V., Uri, I., Bloom, A. I., Gross, D. J.

    Published in Endocrine (01-06-2018)
    “…Background Liver metastases are common in patients with neuroendocrine tumors (NETs), having a negative impact on disease prognosis. The options for selective…”
    Get full text
    Journal Article
  4. 4

    Epigenetic pathway inhibitors represent potential drugs for treating pancreatic and bronchial neuroendocrine tumors by Lines, K E, Stevenson, M, Filippakopoulos, P, Müller, S, Lockstone, H E, Wright, B, Grozinsky-Glasberg, S, Grossman, A B, Knapp, S, Buck, D, Bountra, C, Thakker, R V

    Published in Oncogenesis (New York, NY) (15-05-2017)
    “…Cancer is associated with alterations in epigenetic mechanisms such as histone modifications and methylation of DNA, and inhibitors targeting epigenetic…”
    Get full text
    Journal Article
  5. 5

    Current size criteria for the management of neuroendocrine tumors of the appendix: are they valid? Clinical experience and review of the literature by Grozinsky-Glasberg, S, Alexandraki, K I, Barak, D, Doviner, V, Reissman, P, Kaltsas, G A, Gross, D J

    Published in Neuroendocrinology (01-01-2013)
    “…We evaluated the latest pathological criteria for completion right hemicolectomy (RHC) in patients with appendiceal neuroendocrine tumors (ANETs) with emphasis…”
    Get more information
    Journal Article
  6. 6

    Prognostic value of post-thyroidectomy thyroglobulin levels in patients with differentiated thyroid cancer by Polachek, A., Hirsch, D., Tzvetov, G., Grozinsky-Glasberg, S., Slutski, I., Singer, J., Weinstein, R., Shimon, I., Benbassat, C. A.

    Published in Journal of endocrinological investigation (01-12-2011)
    “…Background: Thyroglobulin is an excellent biological marker of persistent or recurrent thyroid cancer during long-term follow-up. Most studies investigated its…”
    Get full text
    Journal Article
  7. 7

    New drugs in the therapy of neuroendocrine tumors by Grozinsky-Glasberg, S., Gross, D. J.

    Published in Journal of endocrinological investigation (01-11-2012)
    “…Neuroendocrine tumors (NET) are a rare and heterogeneous group of neoplasms of a relatively indolent nature whose incidence and prevalence are increasing…”
    Get full text
    Journal Article
  8. 8

    The potential role of mTOR inhibitors in the treatment of endocrine tumors by Grozinsky-Glasberg, S., Shimon, I.

    Published in Journal of endocrinological investigation (01-04-2010)
    “…Mammalian target of rapamycin (mTOR), a main protein kinase in the phosphoinositide 3-kinase/Akt/p70S6K signaling pathway, is an important intracellular…”
    Get full text
    Journal Article
  9. 9

    Total versus hemithyroidectomy for microscopic papillary thyroid cancer by Gershinsky, M., Barnett-Griness, O., Stein, N., Hirsch, D., Tzvetov, G., Bardicef, O., Pauker, J., Grozinsky-Glasberg, S., Ish-Shalom, S., Slutski, I., Shimon, I., Benbassat, C.

    Published in Journal of endocrinological investigation (01-05-2012)
    “…Background: No increased mortality has been reported in patients with thyroid papillary microcarcinoma (PMC); however, neck recurrences and distant metastases…”
    Get full text
    Journal Article
  10. 10

    Clinically silent chromaffin-cell tumors: Tumor characteristics and long-term prognosis in patients with incidentally discovered pheochromocytomas by Grozinsky-Glasberg, S., Szalat, A., Benbassat, C. A., Gorshtein, A., Weinstein, R., Hirsch, D., Shraga-Slutzky, I., Tsvetov, G., Gross, D. J., Shimon, I.

    Published in Journal of endocrinological investigation (01-11-2010)
    “…Background : Chromaffin-cell tumors (CCT), a rare group of catecholamine producing endocrine neoplasms, are traditionally suspected and diagnosed in patients…”
    Get full text
    Journal Article
  11. 11

    Twenty-year experience with early surgery for craniosynostosis: I. Isolated craniofacial synostosis--results and unsolved problems by McCarthy, J G, Glasberg, S B, Cutting, C B, Epstein, F J, Grayson, B H, Ruff, G, Thorne, C H, Wisoff, J, Zide, B M

    Published in Plastic and reconstructive surgery (1963) (01-08-1995)
    “…Early surgery for isolated craniosynostosis is designed to improve morphology, to prevent functional disturbances, and equally important, to enhance the…”
    Get more information
    Journal Article
  12. 12

    Twenty-year experience with early surgery for craniosynostosis: II. The craniofacial synostosis syndromes and pansynostosis--results and unsolved problems by McCarthy, J G, Glasberg, S B, Cutting, C B, Epstein, F J, Grayson, B H, Ruff, G, Thorne, C H, Wisoff, J, Zide, B M

    Published in Plastic and reconstructive surgery (1963) (01-08-1995)
    “…As the second of a two-part series, 76 patients with pansynostosis and craniofacial synostosis syndromes were retrospectively analyzed. Diagnoses included…”
    Get more information
    Journal Article
  13. 13

    An outcome-based study of aesthetic surgery in a clinic setting by Zweifler, M, Glasberg, S B

    Published in Annals of plastic surgery (01-04-2000)
    “…Previous studies have addressed the difficulties in training residents in aesthetic surgery. The purpose of this study is to analyze patient satisfaction with…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Clear cell carcinoma arising in extraovarian endometriosis: report of three cases and review of the literature by Hitti, I F, Glasberg, S S, Lubicz, S

    Published in Gynecologic oncology (01-12-1990)
    “…The literature on malignancy arising in extraovarian endometriosis comprises only three cases of clear cell carcinoma. We wish to report the clinical features…”
    Get more information
    Journal Article
  16. 16

    Soluble CD30, Acute Rejection, and Graft Survival: Pre- and 6-Month Post-Transplant Determinations—When Is the Best Time to Measure? by de Holanda, M.I., Matuck, T., de Carvalho, D.d.B.M., Domingues, E.M.F.L., Curvo, R., Glasberg, D.S., Santos, A.M.G., Borela, Á.M., Pôrto, L.C.

    Published in Transplantation proceedings (01-04-2018)
    “…Pretransplantation soluble CD30 (sCD30) has been shown to be a good predictor of acute rejection (AR) and graft loss. This study aimed to evaluate the…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Midface distraction advancement in the canine without osteotomies by Staffenberg, D A, Wood, R J, McCarthy, J G, Grayson, B H, Glasberg, S B

    Published in Annals of plastic surgery (01-05-1995)
    “…Midface hypoplasia, often associated with exorbitism and malocclusion, has been traditionally corrected by using Le Fort advancement osteotomies through wide…”
    Get more information
    Journal Article
  19. 19

    Long-range surface plasmon resonances in grating-waveguide structures by Glasberg, S., Sharon, A., Rosenblatt, D., Friesem, A. A.

    Published in Applied physics letters (10-03-1997)
    “…Resonant grating-waveguide structures were used for the excitation of long-range surface plasmons. Resonance spectral bandwidths of 1.9 nm were experimentally…”
    Get full text
    Journal Article
  20. 20